Indeed, phenformin was around 100-fold more potent than metformin in reducing the viability of T-ALL cells in vitro, correlating with greater potency in phosphorylation of AMPK and ACC. This evidence concerns the gene PRKAA1 and acute lymphoblastic leukemia.